![The Alliance for Regenerative Medicine Releases Statement of Principles on Genome Editing]()
by admin | Aug 28, 2019 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
Washington, D.C. – August 27, 2019 – The Alliance for Regenerative Medicine (ARM), the international advocacy organization representing the cell and gene therapy and broader regenerative medicine sector, today released a Therapeutic Developers’ Statement of...
![The Alliance for Regenerative Medicine Releases Statement of Principles on Genome Editing]()
by admin | Aug 27, 2019 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
In a multi-institutional research project, UC San Diego School of Medicine researchers have teamed up to create a human cell model of type 1 diabetes that includes a vascularized human pancreatic islet in a dish. Pictured are blood vessels in green and islets (cell...
![The Alliance for Regenerative Medicine Releases Statement of Principles on Genome Editing]()
by admin | Aug 23, 2019 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
Mayo Clinic’s Life Sciences Incubator, UNF’s Center for Entrepreneurship and Innovation, “a powerful addition” to the city. by: Katie Garwood – Jacksonville Daily Record Vic Nole, executive director of the Life Sciences Incubator. In the six years since Jim...
![The Alliance for Regenerative Medicine Releases Statement of Principles on Genome Editing]()
by admin | Aug 23, 2019 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
Construction began on the Discovery and Innovation Building in 2017. By Katie Garwood – Jacksonville Daily Record Above photo from left, Dr. Kent Thielen, CEO of Mayo Clinic in Florida; Christina Zorn, chief administrative officer, Mayo Clinic in Florida;...
by admin | Aug 20, 2019 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
The California Institute for Regenerative Medicine (CIRM) has awarded a $4.96 million grant to Sanford Burnham Prebys Professor Evan Y. Snyder, M.D., Ph.D. The funding will allow Snyder to complete pre-investigational new drug (IND)-enabling studies, a step toward...
